Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS
290.54 Down 0.94(0.32%) 4:00PM EDT
|After Hours : 289.99 Down 0.55 (0.19%) 7:58PM EDT
Get the big picture on all your investments.
Prev Close:291.48
Open:291.00
Bid:287.30 x 100
Ask:298.00 x 100
1y Target Est:346.84
Beta:1.34
Next Earnings Date:23-Apr-14BIIB Earnings announcement
Day's Range:289.76 - 296.00
52wk Range:194.66 - 358.89
Volume:1,283,744
Avg Vol (3m):1,788,190
Market Cap:68.68B
P/E (ttm):37.20
EPS (ttm):7.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.32%68.68B
PFEUp 0.53%193.08B

Key Statistics

Forward P/E (1 yr):20.71
P/S (ttm):9.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :11.31
Quarterly EPS Est (Mar-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback